OJOG  Vol.7 No.7 , July 2017
Subclinical Hypothyroidism and Isolated Hypothyroxinemia during Pregnancy and Their Association with Pregnancy Outcome: A 2-Year Study
INTRODUCTION: Overt hypothyroidism in pregnancy is associated with adverse outcomes, but the effects of subclinical hypothyroidism and isolated hypothyroxinemia on pregnancy outcomes are still controversial. Subclinical hypothyroidism might be associated with preterm delivery, low Apgar score, fetal death and miscarriages and isolated hypothyroxinemia with preterm labor, high birth weight and neurocognitive deficits in children. Other studies show no association with any complications at all. In the present study we tried to estimate whether maternal subclinical hypothyroidism and isolated hypothyroxinemia are associated with complications during pregnancy in our population which represents the pregnant population of Western Greece. METHODS: In a total of 469 pregnant women, third trimester serum was assayed for thyroid-stimulating hormone (TSH) and free thyroxine (free T4). Thyroid hypofunction was defined as 1) subclinical hypothyroidism with TSH levels above 3 mIU/L for the 3rd trimester and normal free T4 and 2) isolated hypothyroxinemia with TSH levels below 3 mIU/L for the 3rd trimester and free T4 below the 5th percentile. The results were associated with birth weight, week of labor, history of miscarriages and demographic characteristics. Patients with thyroid hypofunction were compared with euthyroid patients (TSH and free T4 between normal limits). The results were analyzed with one-way ANOVA and χ2 test. RESULTS: Subclinical hypothyroidism was documented in 10.9% and isolated hypothyroxinemia in 21.7% of pregnant women. Subclinical hypothyroidism was not associated with birth weight, week of labor, or history of miscarriages. On the contrary, hypothyroxinemia was associated with high birth weight (P < 0.05). CONCLUSION: In our study, we did not find a link between subclinical hypothyroidism and adverse pregnancy outcomes. Similarly, hypothyroxinemia was not associated with pregnancy complications. However, it was associated with higher birth weight. Our studies contribute to our understanding, whether or not subclinical hypothyroidism and isolated hypothyroxinemia are associated with pregnancy adverse outcomes and whether treatment and test for hypothyroidism should become routine during pregnancy.
Cite this paper
Kalampoki, L. , Tsanadis, G. and Stefos, T. (2017) Subclinical Hypothyroidism and Isolated Hypothyroxinemia during Pregnancy and Their Association with Pregnancy Outcome: A 2-Year Study. Open Journal of Obstetrics and Gynecology, 7, 693-701. doi: 10.4236/ojog.2017.77069.
[1]   Mannisto, T., Vaarasmaki, M., Pouta, A., Hartikainen, A.L., Ruokonen, A., Surcel, H.M, et al. (2010) Thyroid Dysfunction and Autoantibodies during Pregnancy as Predictive Factors of Pregnancy Complications and Maternal Morbidity in Later Life. Journal of Clinical Endocrinology & Metabolism, 95, 1084-1094.

[2]   Glinoer, D. (1997) The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology. Endocrine Reviews, 18, 404-433.

[3]   Moleti, M., Trimarchi, F. and Vermiglio, F. (2014) Thyroid Physiology in Pregnancy. Endocrine Practice, 20, 589-596.

[4]   Skjoldebrand, L., Brundin, J., Carlstrom, A. and Pettersson, T. (1982) Thyroid Associated Components in Serum during Normal Pregnancy. Acta Endocrinology (Copenh), 100, 504-511.

[5]   Vanderpump, M.P. and Tunbridge, W.M. (2002) Epidemiology and Prevention of Clinical and Subclinical Hypothyroidism. Thyroid, 12, 839-847.

[6]   Vanderpump, M.P.J. (2011) The Epidemiology of Thyroid Disease. British Medical Bulletin, 99, 39-51.

[7]   Krassas, G.E., et al. (2010) Thyroid Function and Human Reproductive Health. Endocrine Reviews, 31, 702-755.

[8]   Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E., Soldin, O., Sullivan, S. and Wiersinga, W. (2011) Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum. Thyroid, 21, 1081-1125.

[9]   Karakosta, P., Alegakis, D., Georgiou, V., Roumeliotaki, T., Fthenou, E., Vassilaki, M., et al. (2012) Thyroid Dysfunction and Autoantibodies in Early Pregnancy Are Associated with Increased Risk of Gestational Diabetes and Adverse Birth Outcomes. Journal of Clinical Endocrinology & Metabolism, 97, 4464-4472.

[10]   Su, P.Y., Huang, K., Hao, J.H., Xu, Y.Q., Yan, S.Q., Li, T., et al. (2011) Maternal Thyroid Function in the First Twenty Weeks of Pregnancy and Subsequent Fetal and Infant Development: A Prospective Population-Based Cohort Study in China. Journal of Clinical Endocrinology & Metabolism, 96, 3234-3241.

[11]   Stagnaro-Green, A. (2009) Maternal Thyroid Disease and Preterm Delivery. Journal of Clinical Endocrinology & Metabolism, 94, 21-25.

[12]   Mannisto, T., Mendola, P., Reddy, U. and Laughon, S.K. (2013) Neonatal Outcomes and Birth Weight in Pregnancies Complicated by Maternal Thyroid Disease. American Journal of Epidemiology, 178, 731-740.

[13]   Sahu, M.T., Das, V., Mittal, S., Agarwal, A. and Sahu, M. (2010) Overt and Subclinical Thyroid Dysfunction among Indian Pregnant Women and Its Effect on Maternal and Fetal Outcome. Archives of Gynecology and Obstetrics, 281, 215-220.

[14]   Poppe, K. and Glinoer, D. (2003) Thyroid Autoimmunity and Hypothyroidism before and during Pregnancy. Human Reproduction Update, 9, 149-161.

[15]   Blazer, S., Moreh-Waterman, Y., Miller-Lotan, R., Tamir, A. and Hochberg, Z. (2003) Maternal Hypothyroidism May Affect Fetal Growth and Neonatal Thyroid Function. Obstetrics & Gynecology, 102, 232.

[16]   Min, H., Dong, J., Wang, Y., Wang, Y., Teng, W., Xi, Q. and Chen, J. (2016) Maternal Hypothyroxinemia—Induced Neurodevelopmental Impairments in the Progeny. Molecular Neurobiology, 53, 1613-1624

[17]   Korevaar, T., Muetzel, R., Medici, M., Chaker, L., Jaddoe, V.W., de Rijke, Y.B., Steegers, E.A., Visser, T.J., White, T., Tiemeier, H. and Peeters, R.P. (2016) Association of Maternal Thyroid Function during Early Pregnancy with Offspring IQ and Brain Morphology in Childhood a Population-Based Prospective Cohort Study. The Lancet Diabetes & Endocrinology, 4, 35-43.

[18]   Taylor, P.N., Okosieme, O.E. Premawardhana, L. and Lazarus, J.H. (2015) Should All Women Be Screened for Thyroid Dysfunction in Pregnancy? Womens Health, 11, 295-307.

[19]   Usadi, R.S. and Meriam, K.S. (2016) Subclinical Hypothyroidism Impact on Fertility Obstetric and Neonatal Outcomes. Seminars in Reproductive Medicine, 34, 337-342.

[20]   Negro, R. (2011) Thyroid Disease in Pregnancy. Endocrinology and Metabolism, 25, 927-943.

[21]   Idris, I., Shrinivasan, R., Simm, A. and Page, R.C. (2005) Maternal Hypothyroidism in Early and Late Gestation; Effects on Neonatal and Obstetric Outcome. Clinical Endocrinology, 63, 560-565.

[22]   Cleary-Goldman, J., Malone, F.D., Lambert-Messerlian, G., Sullivan, L., Canick, J., Porter, T.F., Luthy, D., Gross, S., Bianchi, D.W. and D'Alton, M.E. (2008) Maternal Thyroid Hypofunction and Pregnancy Outcome. Obstetrics & Gynecology, 112, 85-92.

[23]   Pop, V.J., Kuijpens, J.L., van Baar, A.L., et al. (1999) Low Maternal Free Thyroxine Concentrations during Early Pregnancy Are Associated with Impaired Psychomotor Development in Infancy. Clinical Endocrinology (Oxf), 50, 149-155.

[24]   Moleti, M., Trimarchi, F. and Vermiglio, F. (2011) Doubts and Concerns about Isolated Maternal Hypothyroxinemia. Journal of Thyroid Research, 2011, Article ID: No. 463029, 7.

[25]   Abalovich, M., Guiterrez, S., Alcaraz, G., Maccallini, G., Garcia, A. and Levalle, O. (2002) Overt and Subclinical Hypothyroidism Complicating Pregnancy. Thyroid, 12, 63-68.

[26]   Allan, W.C., Haddow, J.E., Palomaki, G.E., Williams, J.R., Mitchell, M.L., Hermos, R.J., Faix, J.D. and Klein, R.Z. (2000) Maternal Thyroid Deficiency and Pregnancy Complications: Implications for Population Screening. Journal of Medical Screening, 7, 127-130.

[27]   Casey, B.M. (2011) Subclinical Thyroid Dysfunction during Pregnancy. Clinical Obstetrics and Gynecology, 54, 493-498.

[28]   Benhadi, N., Wiersinga, W.M., Reitsma, J.B., Vrijkotte, T.G. and Bonsel, G.J. (2009) Higher Maternal TSH Levels in Pregnancy Are Associated with Increased Risk for Miscarriage, Fetal or Neonatal Death. European Journal of Endocrinology, 160, 985-991.

[29]   Mannisto, T., Vaarasmaki, M., Pouta, A., Hartikainen, A.L., Ruokonen, A., Surcel, H.M., Bloigu, A., Jarvelin, M.R. and Suvanto-Luukkonen, E. (2009) Perinatal Outcome of Children Born to Mothers with Thyroid Dysfunction or Antibodies: A Prospective Population-Based Cohort Study. Journal of Clinical Endocrinology & Metabolism, 94, 772-779.

[30]   Casey, B.M., Dashe, J.S., Wells, C.E., et al. (2005) Subclinical Hypothyroidism and Pregnancy Outcomes. Obstetrics & Gynecology, 105, 239-245.

[31]   Casey, B.M., Dashe, J.S., Spong, C.Y., et al. (2007) Perinatal Significance of Isolated Maternal Hypothyroxinemia Identified in the First Half of Pregnancy. Obstetrics & Gynecology, 109, 1129.

[32]   Hamm, M.P., Cherry, N.M., Martin, J.W., et al. 2009) The Impact of Isolated Maternal Hypothyroxinemia on Perinatal Morbidity. Journal of Obstetrics and Gynaecology Canada, 31, 1015-1021.